China Pharma Holding (STU:XQJ) Cyclically Adjusted Book per Share: €10,245.51 (As of Mar. 2026)


STU:XQJ China Pharma Holding Inc STU:XQJ
26 GF Score
Price €26.80
GF Value €10.05
! 3 Warning Signs
View Full Analysis

What is China Pharma Holding Cyclically Adjusted Book per Share?

China Pharma Holding STU:XQJ 26 Cyclically Adjusted Book per Share is €10,245.51 as of Mar. 2026. GuruFocus rates STU:XQJ with a GF Score™ of 26/100 and a GF Value™ of €10.05. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

China Pharma Holding's adjusted book value per share for the three months ended in Mar. 2026 was €0.790. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10,245.51 for the trailing ten years ended in Mar. 2026.

During the past 12 months, China Pharma Holding's average Cyclically Adjusted Book Growth Rate was -31.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -29.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -25.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of China Pharma Holding was 24.90% per year. The lowest was -29.10% per year. And the median was -3.40% per year.

As of today (2026-07-11), China Pharma Holding's current stock price is €26.80. China Pharma Holding's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €10,245.51. China Pharma Holding's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of China Pharma Holding was 0.53. The lowest was 0.01. And the median was 0.10.


China Pharma Holding  (STU:XQJ) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

China Pharma Holding's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=26.80/10245.51
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of China Pharma Holding was 0.53. The lowest was 0.01. And the median was 0.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


China Pharma Holding Cyclically Adjusted Book per Share Related Terms


China Pharma Holding Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for China Pharma Holding's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Pharma Holding Cyclically Adjusted Book per Share Chart

China Pharma Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 782.40 662.66 2,312.82 4,262.76 5,659.89

China Pharma Holding Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,441.73 4,578.31 3,829.93 5,659.89 10,245.51

STU:XQJ vs TXMD, RMTI, AYTU: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Cyclically Adjusted PB Ratio falls into.


STU:XQJ
26GF Score
China Pharma Holding Inc STU:XQJ
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Pharma Holding Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China Pharma Holding's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.79/116.3033*116.3033
=0.790

Current CPI (Mar. 2026) = 116.3033.

China Pharma Holding Quarterly Data

Book Value per Share CPI Adj_Book
201606 685.000 101.400 785.678
201609 665.023 102.400 755.316
201612 641.908 102.600 727.642
201703 627.874 103.200 707.595
201706 584.563 103.100 659.424
201709 549.989 104.100 614.462
201712 418.333 104.500 465.584
201803 414.379 105.300 457.679
201806 403.644 104.900 447.523
201809 370.701 106.600 404.444
201812 305.115 106.500 333.201
201903 311.448 107.700 336.327
201906 294.678 107.700 318.217
201909 285.517 109.800 302.428
201912 95.563 111.200 99.949
202003 87.172 112.300 90.280
202006 85.724 110.400 90.308
202009 76.690 111.700 79.850
202012 72.308 111.500 75.423
202103 66.143 112.662 68.281
202106 59.516 111.769 61.930
202109 61.337 112.215 63.571
202112 56.063 113.108 57.647
202203 49.990 114.335 50.851
202206 38.465 114.558 39.051
202209 28.347 115.339 28.584
202212 27.000 115.116 27.279
202303 25.805 115.116 26.071
202306 17.623 114.558 17.892
202309 9.976 115.339 10.059
202312 6.431 114.781 6.516
202403 5.148 115.227 5.196
202406 4.011 114.781 4.064
202409 3.293 115.785 3.308
202412 2.268 114.893 2.296
202503 1.976 115.116 1.996
202506 1.718 114.907 1.739
202509 1.411 115.471 1.421
202512 1.251 115.832 1.256
202603 0.790 116.303 0.790

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €10,245.51 mean?
China Pharma Holding (STU:XQJ) has a Cyclically Adjusted Book per Share of €10,245.51 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on China Pharma Holding and its competitors.
Is China Pharma Holding's Cyclically Adjusted Book per Share too high?
China Pharma Holding's current Cyclically Adjusted Book per Share is €10,245.51. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Cyclically Adjusted Book per Share compare to TXMD and RMTI?
China Pharma Holding's Cyclically Adjusted Book per Share of €10,245.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on China Pharma Holding and its competitors. China Pharma Holding's current Cyclically Adjusted Book per Share is €10,245.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Cyclically Adjusted Book per Share of €10,245.51. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is €10,245.51. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Cyclically Adjusted Book per Share is €10,245.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Pharma Holding (STU:XQJ) Overvalued in 2026?

Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued. The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.

Key valuation signals for STU:XQJ:

  • Cyclically Adjusted Book per Share: €10,245.51
  • GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Pharma Holding Business Description

Other Exchanges CPHI:USA
Address No. 17, Jinpan Road, Second Floor, Jiahai Building, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score

Get the complete analysis for STU:XQJ

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.80
Price
€10.05
GF Value